Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Matthews

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised targetYongyuth Yuthavong, Bongkoch Tarnchompoo, Tirayut Vilaivan, et al.
Iscience|January 23, 2024
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expressionXiaodong Zhuang, Giulia Gallo, Parul Sharma, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
Design, synthesis and in vitro evaluation of potent, novel, small molecule inhibitors of plasminogen activator inhibitor-1Adrian Folkes, S David Brown, Lynne E Canne, et al.
Science Translational Medicine|July 20, 2022
A semaphorin-plexin-Rasal1 signaling pathway inhibits gastrin expression and protects against peptic ulcersRui Xu, Carsten Höß, Jakub M Swiercz, et al.
Nature Communications|February 27, 2021
Mechanochemical control of epidermal stem cell divisions by B-plexinsChen Jiang, Ahsan Javed, Laura Kaiser, et al.
BMJ (Clinical Research Ed.)|October 18, 2008
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial diseaseJill Belch, Angus MacCuish, Iain Campbell, et al.
Journal of Medicinal Chemistry|January 5, 2012
Discovery of a novel class of potent and orally bioavailable sphingosine 1-phosphate receptor 1 antagonistsMohamed A Ibrahim, Henry W B Johnson, Joon Won Jeong, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2017
The outstanding questions in transplantation: It's about time…Jamil Azzi, Giorgio Raimondi, Valeria Mas, et al.
Journal of Medicinal Chemistry|June 24, 2011
Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potentialJose M Coteron, María Marco, Jorge Esquivias, et al.
Cell|July 4, 2017
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13Anup Aggarwal, Maloy K Parai, Nishant Shetty, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised targetYongyuth Yuthavong, Bongkoch Tarnchompoo, Tirayut Vilaivan, et al.
Iscience|January 23, 2024
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expressionXiaodong Zhuang, Giulia Gallo, Parul Sharma, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
Design, synthesis and in vitro evaluation of potent, novel, small molecule inhibitors of plasminogen activator inhibitor-1Adrian Folkes, S David Brown, Lynne E Canne, et al.
Science Translational Medicine|July 20, 2022
A semaphorin-plexin-Rasal1 signaling pathway inhibits gastrin expression and protects against peptic ulcersRui Xu, Carsten Höß, Jakub M Swiercz, et al.
Nature Communications|February 27, 2021
Mechanochemical control of epidermal stem cell divisions by B-plexinsChen Jiang, Ahsan Javed, Laura Kaiser, et al.
BMJ (Clinical Research Ed.)|October 18, 2008
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial diseaseJill Belch, Angus MacCuish, Iain Campbell, et al.
Journal of Medicinal Chemistry|January 5, 2012
Discovery of a novel class of potent and orally bioavailable sphingosine 1-phosphate receptor 1 antagonistsMohamed A Ibrahim, Henry W B Johnson, Joon Won Jeong, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2017
The outstanding questions in transplantation: It's about time…Jamil Azzi, Giorgio Raimondi, Valeria Mas, et al.
Journal of Medicinal Chemistry|June 24, 2011
Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potentialJose M Coteron, María Marco, Jorge Esquivias, et al.
Cell|July 4, 2017
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13Anup Aggarwal, Maloy K Parai, Nishant Shetty, et al.
Pageof 12